Medical Evaluation

When a woman experiences concerning symptoms, a pelvic exam, including a rectovaginal exam, and a general physical exam should be performed. If the exam is abnormal, women should undergo a transvaginal or pelvic ultrasound to evaluate the ovaries.

If the exam is normal, it is reasonable to wait 2–3 weeks to see if the symptoms resolve. If they do not, then a transvaginal or pelvic ultrasound should be performed. If an abnormality of the ovaries is found, additional radiographic studies, such as a CT scan or MRI, and a blood test for CA 125, may be performed. CA 125 is elevated in approximately 80 percent of women with advanced stage epithelial ovarian cancer, but elevations can occur for reasons other than ovarian cancer. If you suspect or have been diagnosed with ovarian cancer, it is important to see a gynecologic oncologist [hyperlink to Find A Gynecologic Oncologist.. For more information about CA 125, read a brochure developed by Foundation for Women’s Cancer “Understanding CA 125 Levels: A Patient’s Guide.”

Spotlight

Hear from Dr. Anil Sood, the Foundation’s Research Chairman, and Carol Brown, 2014 SGO Program Chair, about research of interest to women and the public presented at the 2014 SGO Annual Meeting on Women’s Cancer. Watch the video

Awareness

A new SGO Clinical Practice Statement states women diagnosed with epithelial ovarian, tubal, and peritoneal cancers should be considered for genetic counseling and testing, even in the absence of a family history.

Education

The next Gynecologic Cancer Survivors Course Friday, May 2, 2014 in Long Island, NY. For more information on courses, click here.